Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Operating Income
6,658.00
5,985.00
5,855.00
5,033.00
5,048.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
6,658.00
5,985.00
5,855.00
5,033.00
5,048.00
Expenditure (Ex Depriciation)
Stock Adjustments
-190.00
66.00
-145.00
-303.00
1.00
Raw Materials Consumed
2,665.00
2,193.00
2,378.00
2,188.00
2,027.00
Power & Fuel Cost
120.00
108.00
97.00
94.00
100.00
Employee Cost
1,292.00
1,117.00
1,011.00
904.00
1,105.00
Operating Expenses
287.00
261.00
271.00
290.00
157.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
534.00
414.00
397.00
121.00
243.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
195.00
157.00
142.00
240.00
96.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,428.00
4,804.00
4,525.00
3,817.00
4,344.00
Operating Profit (PBDIT) excl Other Income
1,229.00
1,181.00
1,329.00
1,216.00
703.00
Other Income
56.00
45.00
63.00
33.00
82.00
Operating Profit (PBDIT)
1,286.00
1,227.00
1,393.00
1,250.00
786.00
Interest
237.00
213.00
175.00
154.00
256.00
Profit before Depriciation and Tax
1,049.00
1,013.00
1,217.00
1,095.00
529.00
Depreciation
312.00
260.00
244.00
249.00
320.00
Profit Before Taxation & Exceptional Items
737.00
753.00
972.00
845.00
208.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
727.00
747.00
972.00
840.00
105.00
Provision for Tax
199.00
185.00
269.00
233.00
4.00
Profit After Tax
527.00
561.00
702.00
607.00
100.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
2,196.00
1,695.00
1,743.00
1,368.00
1,343.00
Profit Available for appropriations
2,694.00
2,227.00
2,406.00
1,976.00
1,427.00
Appropriations
2,694.00
2,227.00
2,406.00
1,976.00
1,427.00
Equity Dividend (%)
20.00%
20.00%
30.00%
10.00%
25.00%
Earnings Per Share
27.54
29.42
36.62
21.68
4.62
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 25.28% vs 12.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 41.02% vs 0.78% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -31.99% vs -0.44% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 97.18% vs 0.48% in Mar 2024
Compare Profit and Loss Results of Emcure Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,658.00
3,917.00
2,741.00
69.98%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,658.00
3,917.00
2,741.00
69.98%
Expenditure (Ex Depriciation)
Stock Adjustments
-190.00
0.00
-190.00
0%
Raw Materials Consumed
2,665.00
1,316.00
1,349.00
102.51%
Power & Fuel Cost
120.00
83.00
37.00
44.58%
Employee Cost
1,292.00
687.00
605.00
88.06%
Operating Expenses
287.00
143.00
144.00
100.70%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
534.00
429.00
105.00
24.48%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
195.00
95.00
100.00
105.26%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,428.00
2,886.00
2,542.00
88.08%
Operating Profit (PBDIT) excl Other Income
1,229.00
1,031.00
198.00
19.20%
Other Income
56.00
38.00
18.00
47.37%
Operating Profit (PBDIT)
1,286.00
1,070.00
216.00
20.19%
Interest
237.00
11.00
226.00
2,054.55%
Profit before Depriciation and Tax
1,049.00
1,058.00
-9.00
-0.85%
Depreciation
312.00
171.00
141.00
82.46%
Profit Before Taxation & Exceptional Items
737.00
887.00
-150.00
-16.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
727.00
887.00
-160.00
-18.04%
Provision for Tax
199.00
227.00
-28.00
-12.33%
Profit After Tax
527.00
659.00
-132.00
-20.03%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,196.00
2,517.00
-321.00
-12.75%
Profit Available for appropriations
2,694.00
3,176.00
-482.00
-15.18%
Appropriations
2,694.00
3,176.00
-482.00
-15.18%
Equity Dividend (%)
20%
1550%
-1,530.00
Earnings Per Share
27.54
42.45
-14.91
-35.12%
Profit And Loss - Net Sales
Net Sales 4,381.92 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.28% vs 12.57% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 623.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 41.02% vs 0.78% in Mar 2024
Profit And Loss - Interest
Interest 112.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -31.99% vs -0.44% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 317.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 97.18% vs 0.48% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
